Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.5K Buy
58
+4
+7% +$1.43K 0.01% 364
2025
Q4
$17.7K Buy
54
+20
+59% +$6.34K 0.01% 367
2025
Q3
$9.6K Hold
34
﹤0.01% 462
2025
Q2
$9.49K Hold
34
﹤0.01% 456
2025
Q1
$10.6K Hold
34
﹤0.01% 429
2024
Q4
$8.86K Hold
34
﹤0.01% 456
2024
Q3
$11K Hold
34
﹤0.01% 420
2024
Q2
$10.6K Hold
34
﹤0.01% 406
2024
Q1
$9.67K Hold
34
0.01% 450
2023
Q4
$9.79K Buy
+34
New +$9.26K 0.01% 426

Other funds holding AMGN

Tidemark's AMGN Position: Q1 2026 in Review

Tidemark increased its Amgen (AMGN) stake by 7.4% in Q1 2026, buying an estimated $1.43K and bringing the position to 58 shares worth $20.5K. The position accounts for 0.01% of the portfolio, ranked #364.

Tidemark first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Tidemark held 58 shares of Amgen worth $20.5K as of Q1 2026.
  • Tidemark bought 4 Amgen shares in Q1 2026, an estimated $1.43K.
  • Amgen made up 0.01% of Tidemark's portfolio in Q1 2026, its #364 holding.
  • Tidemark first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Tidemark's 13F filing for Q1 2026, filed 7 May 2026.